Temsirolimus combined with sorafenib in hepatocellular carcinoma: a phase I dose-finding trial with pharmacokinetic and biomarker correlates
Kelley, R. K., Nimeiri, H. S., Munster, P. N., Vergo, M. T., Huang, Y., Li, C.- M., Hwang, J., Mulcahy, M. F., Yeh, B. M., Kuhn, P., Luttgen, M. S., Grabowsky, J. A., Stucky-Marshall, L., Korn, W. M.,Volume:
24
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdt109
Date:
July, 2013
File:
PDF, 142 KB
english, 2013